- No public price.
- Not disclosed
- Not disclosed
- —
- —
- KR


Airs Medical
by AIRS Medical Inc. · KR
FDA-cleared AI MRI reconstruction (SwiftMR) and quantification (SwiftSight) for imaging centers and radiologists.
On this page
Editorial rating 2.5 / 5
- Regulatory & Compliance18/28
FDA cleared (7 K-numbers on record)
- Clinical Integration0/6.6
No EHR integrations listed
- Evidence Strength7.3/26
1 peer-reviewed paper
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency2.5/5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance18/18
FDA cleared (7 K-numbers on record)
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/4
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/2
None of the top-3 EHRs covered
- Peer-reviewed papers7/18
1 peer-reviewed paper
- RCT / meta-analysis / systematic review0/8
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Pricing transparency3/5
Pricing on request, no public amounts
FDA-cleared AI MRI reconstruction (SwiftMR) and quantification (SwiftSight) for imaging centers and radiologists.
No public price.
Evidence record
510(k)K261612 (opens in new tab)October 1, 2026
SwiftSight-BodyComposition
510(k)K261349 (opens in new tab)July 24, 2026
SwiftMR
510(k)K253775 (opens in new tab)March 26, 2026
SwiftMR
510(k)K251483 (opens in new tab)September 23, 2025
SwiftSight-Brain
510(k)K230854 (opens in new tab)October 27, 2023
SwiftMR
Show 2 more
510(k)K220416 (opens in new tab)May 25, 2022
SwiftMR
510(k)K210999 (opens in new tab)October 14, 2021
SwiftMR
1 study on PubMed: 1 other, published 2026. Read the literature summary
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Airs Medical record, https://medaiverdict.com/tools/airs-medical, version November 2, 2026
Bottom line
AIRS Medical Inc. sells two products. SwiftMR is deep-learning MRI reconstruction that the vendor says cuts scan times by up to 50% on existing scanners, and SwiftSight returns quantitative brain MRI measurements. Press coverage places the company in Seoul. It fits an imaging center that wants more throughput from scanners it already runs and can work from capacity claims that come from the vendor and its customers. No price is public.
What does the vendor claim for SwiftMR?
The vendor says SwiftMR improves image quality, shortens scan times and adds capacity without hardware replacement or workflow disruption. It states compatibility with all MRI scanners from Siemens Healthineers, GE HealthCare, Philips and Canon Medical. The home page example for brain MR angiography is labeled "64% faster" on a 3.0T Siemens MAGNETOM Skyra, and a shoulder case sits beside it.
SwiftSight carries the line "Measure the patient, not the scanner." The vendor describes reproducible brain MRI measurements for longitudinal assessment across scanner vendors and field strengths.
Where has SwiftMR been used in the literature?
Three papers use SwiftMR. One measured signal to noise ratio in postmortem MRI, one built high-resolution 4D MR angiography from TWIST stroke imaging with SwiftMR version 3.0.0.0 (PMID 38893725), and one compared three T2-weighted liver MRI protocols with SwiftMR as one of them. None of the three is a SwiftSight study.
Which products carry an FDA clearance?
FDA's 510(k) records list seven clearances under Airs Medical, Inc., from K210999 (SwiftMR, October 14, 2021) to K261612 (SwiftSight-BodyComposition, October 1, 2026). Five are SwiftMR, one is SwiftSight-Brain, and the body composition version means SwiftSight now reaches beyond the brain. The vendor's home page does not mention FDA clearance.
What do the customer numbers say?
The vendor's pages give two institution counts: "2,000+ healthcare institutions" in 50+ countries in the body text, and 1,700+ institutions in 40+ countries in the page description. Named case studies are the vendor's. 3T Radiology & Research in Miami reports "+56% more daily scan capacity" and "200+ additional patients in the first month", and Invision reports "$1.5M capital saved vs. a new scanner".
Funding was two $20M rounds, a Series B in August 2022 and a Series C in July 2024, and Dealroom puts the total at $44.5M.
The verdict
SwiftMR is the older product, with three clearances by October 2023 and two more in 2026. For a center whose limit is scanner hours it is the product the capacity claims address, and the +56% figure in Miami is a customer statement. A group that compares vendors on security posture or PACS integration has no AIRS Medical statement to compare, because the vendor's pages carry neither.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
What deploys cleanly
Carries FDA 510(k) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
What the literature says
1 peer-reviewed study indexed on PubMed evaluate Airs Medical in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Signal-to-noise ratio improvement in postmortem MRI using deep learning reconstruction (SwiftMR). (opens in new tab)
- Hyodoh H, Shimbashi S, Maruyama R, et al.· Forensic Sci Int· 2026
- Postmortem imaging has become an essential modality for death investigation, with computed tomography (PMCT) being widely adopted as a rapid and objective screening tool. However, the application of postmortem magnetic resonance imaging (PMMRI) remains limited in routine forensic practice, primarily due to the longer acquisition time and the need for high-quality images under time constraints. SwiftMR™ (AIRS Medical, Seoul, Korea) is a deep learning-based reconstruction software designed to enhance MR image quality through denoising and multi-dimensional k-space optimization, allowing…



